I2MC
THE INSTITUTE…
The Institute of Metabolic and Cardiovascular Diseases (I2MC) develops research to understand the pathophysiological mechanisms involved in common chronic non-communicable diseases: obesity, diabetes, thrombosis, atherosclerosis and diseases of the vessels, heart and kidney.
HISTORY
Scientists
Teams
2 RESEARCH
AXES
publications per year
technological platforms
Parent institutions and partners
Main financial supporters
management team
Pierre GOURDY
Deputy Director
Cyrille MAHIEUX
Administrative Director
Frank LEZOUALC'H
Project Manager
Joost SCHANSTRA
Project Manager
Alexia ZAKAROFF
Project Manager
L’organisation de l’I2MC
Research teams
Technological platforms
Administration and support services
Laboratory Council
Scientific advisory board
Actualités
InScience 2023
From June 1 to June 15, 2023, the 3rd edition of...
LiMitAging team’s work in La Dépêche
Un article de la Dépêche du Midi évoque les...
New review from MetaDiab (C. Moro) team in Biochimie
Does housing temperature influence glucose...
DISEASES explained
Type 2 diabetes
Diabetes is a long-term excess of glucose concentration in the blood (hyperglycemia). In the case of type 2 diabetes, this is caused by a disturbance of the carbohydrate metabolism. Even if it appears gradually and insidiously, the disease has serious consequences, even fatal, in the long term.
Cardiovascular diseases
Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions.
Kidney disease
Kidney failure is the result of the slow evolution of the disease that leads to the destruction of the kidneys. It affects more than 82,000 people in France and requires dialysis or transplantation. In 50% of cases, chronic kidney diseases are the consequence of diabetes or high blood pressure.
Obesity
Obesity is an excess of body fat and a change in adipose tissue, which can lead to health problems and shorten life expectancy. Its causes are complex. It results from the interplay of several factors – dietary, genetic, epigenetic and environmental – involved in the development and progression of this chronic disease.
Non-profit and patient associations
L’Afero
A.F.E.R.O is the French Association for Study and Research on Obesity. Its aim is to promote scientific exchanges, the dissemination of knowledge and training in the field of biomedical research on obesity. The AFERO can be considered as the learned society of Obesity in France.
French-speaking Society of Nephrology, Dialysis and Transplantation
The mission of the SFNDT is to support the development of nephrology in all its fields, from clinical nephrology to dialysis and renal transplantation, as well as in all dimensions of care, basic research, epidemiological and clinical advances, and education.
French Federation of Cardiology
Created in 1964, the French Federation of Cardiology is an association recognized as being of public utility since 1977. A collective vocation mobilized to reduce cardiovascular diseases.
Évènements
Derniers tweets
Inserm/UPS UMR 1297 - I2MC Institut des Maladies Métaboliques et Cardiovasculaires
1 avenue Jean Poulhès - BP 84225 - 31432 Toulouse Cedex 4
Tél. : 05 61 32 56 00
Horaires
Du lundi au vendredi
8h30 - 12h30 / 13h45 -16h45
